vs
GLAUKOS Corp（GKOS）与NLIGHT, INC.（LASR）财务数据对比。点击上方公司名可切换其他公司
GLAUKOS Corp的季度营收约是NLIGHT, INC.的1.9倍（$150.6M vs $80.2M），GLAUKOS Corp净利率更高（6.2% vs 0.8%，领先5.4%），NLIGHT, INC.同比增速更快（55.2% vs 41.2%），过去两年NLIGHT, INC.的营收复合增速更高（26.0% vs 25.4%）
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
nLight Inc.是全球领先的高性能半导体激光器、光纤激光器及相关光学组件研发生产商，产品广泛应用于工业精密制造、航空航天与国防、医疗设备、前沿研究等核心领域，客户遍及北美、欧洲及亚太地区。
GKOS vs LASR — 直观对比
营收规模更大
GKOS
是对方的1.9倍
$80.2M
营收增速更快
LASR
高出14.0%
41.2%
净利率更高
GKOS
高出5.4%
0.8%
两年增速更快
LASR
近两年复合增速
25.4%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $150.6M | $80.2M |
| 净利润 | $9.4M | $645.0K |
| 毛利率 | 77.9% | 33.1% |
| 营业利润率 | 9.0% | 66.0% |
| 净利率 | 6.2% | 0.8% |
| 营收同比 | 41.2% | 55.2% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GKOSLASR
| Q1 26 | $150.6M | $80.2M | ||
| Q4 25 | $143.1M | $81.2M | ||
| Q3 25 | $133.5M | $66.7M | ||
| Q2 25 | $124.1M | $61.7M | ||
| Q1 25 | $106.7M | $51.7M | ||
| Q4 24 | $105.5M | $47.4M | ||
| Q3 24 | $96.7M | $56.1M | ||
| Q2 24 | $95.7M | $50.5M |
净利润GKOSLASR
| Q1 26 | $9.4M | $645.0K | ||
| Q4 25 | $-133.7M | $-4.9M | ||
| Q3 25 | $-16.2M | $-6.9M | ||
| Q2 25 | $-19.7M | $-3.6M | ||
| Q1 25 | $-18.1M | $-8.1M | ||
| Q4 24 | $-33.6M | $-25.0M | ||
| Q3 24 | $-21.4M | $-10.3M | ||
| Q2 24 | $-50.5M | $-11.7M |
毛利率GKOSLASR
| Q1 26 | 77.9% | 33.1% | ||
| Q4 25 | -1.1% | 30.7% | ||
| Q3 25 | 78.4% | 31.1% | ||
| Q2 25 | 78.3% | 29.9% | ||
| Q1 25 | 77.2% | 26.7% | ||
| Q4 24 | 72.9% | 2.4% | ||
| Q3 24 | 76.6% | 22.4% | ||
| Q2 24 | 76.4% | 23.5% |
营业利润率GKOSLASR
| Q1 26 | 9.0% | 66.0% | ||
| Q4 25 | -97.7% | -6.7% | ||
| Q3 25 | -12.3% | -10.9% | ||
| Q2 25 | -18.3% | -6.9% | ||
| Q1 25 | -19.4% | -18.6% | ||
| Q4 24 | -27.2% | -55.8% | ||
| Q3 24 | -25.5% | -21.0% | ||
| Q2 24 | -31.3% | -25.1% |
净利率GKOSLASR
| Q1 26 | 6.2% | 0.8% | ||
| Q4 25 | -93.4% | -6.0% | ||
| Q3 25 | -12.2% | -10.3% | ||
| Q2 25 | -15.8% | -5.8% | ||
| Q1 25 | -17.0% | -15.7% | ||
| Q4 24 | -31.8% | -52.7% | ||
| Q3 24 | -22.1% | -18.4% | ||
| Q2 24 | -52.8% | -23.2% |
每股收益（稀释后）GKOSLASR
| Q1 26 | — | $0.01 | ||
| Q4 25 | $-2.34 | $-0.10 | ||
| Q3 25 | $-0.28 | $-0.14 | ||
| Q2 25 | $-0.34 | $-0.07 | ||
| Q1 25 | $-0.32 | $-0.16 | ||
| Q4 24 | $-0.56 | $-0.52 | ||
| Q3 24 | $-0.39 | $-0.21 | ||
| Q2 24 | $-1.00 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.7M | $298.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $670.9M | $429.2M |
| 总资产 | $893.3M | $515.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GKOSLASR
| Q1 26 | $276.7M | $298.2M | ||
| Q4 25 | $90.8M | $98.7M | ||
| Q3 25 | $98.2M | $81.1M | ||
| Q2 25 | $100.8M | $78.8M | ||
| Q1 25 | $114.3M | $82.2M | ||
| Q4 24 | $169.6M | $65.8M | ||
| Q3 24 | $100.1M | $41.5M | ||
| Q2 24 | $68.1M | $49.4M |
股东权益GKOSLASR
| Q1 26 | $670.9M | $429.2M | ||
| Q4 25 | $656.2M | $226.7M | ||
| Q3 25 | $769.5M | $218.5M | ||
| Q2 25 | $765.1M | $216.0M | ||
| Q1 25 | $764.0M | $212.8M | ||
| Q4 24 | $766.9M | $216.4M | ||
| Q3 24 | $668.5M | $235.3M | ||
| Q2 24 | $665.2M | $239.5M |
总资产GKOSLASR
| Q1 26 | $893.3M | $515.7M | ||
| Q4 25 | $893.5M | $315.2M | ||
| Q3 25 | $999.4M | $298.7M | ||
| Q2 25 | $987.0M | $295.3M | ||
| Q1 25 | $966.2M | $290.0M | ||
| Q4 24 | $974.8M | $270.2M | ||
| Q3 24 | $926.5M | $291.3M | ||
| Q2 24 | $919.7M | $294.3M |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GKOS
暂无分部数据
LASR
| Products | $58.2M | 73% |
| Development | $22.0M | 27% |
